Detalles de la búsqueda
1.
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients.
Am J Transplant
; 23(5): 649-658, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36773936
2.
SARS-CoV-2 seroprevalence and determinants for salivary seropositivity among pupils and school staff: a prospective cohort study.
Epidemiol Infect
; 151: e75, 2023 04 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37092673
3.
SARS-CoV-2 infection prevention and control measures in Belgian schools between December 2020 and June 2021 and their association with seroprevalence: a cross-sectional analysis of a prospective cohort study.
BMC Public Health
; 23(1): 898, 2023 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37194008
4.
Poor Antibody Response to BioNTech/Pfizer Coronavirus Disease 2019 Vaccination in Severe Acute Respiratory Syndrome Coronavirus 2-Naive Residents of Nursing Homes.
Clin Infect Dis
; 75(1): e695-e704, 2022 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34864935
5.
Age-dependent seroprevalence of SARS-CoV-2 antibodies in school-aged children from areas with low and high community transmission.
Eur J Pediatr
; 181(2): 571-578, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34455523
6.
Hybrid immunity to SARS-CoV-2 in kidney transplant recipients and hemodialysis patients.
Am J Transplant
; 22(3): 994-995, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34554629
7.
Monoclonal anti-envelope antibody AP33 protects humanized mice against a patient-derived hepatitis C virus challenge.
Hepatology
; 63(4): 1120-34, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26710081
8.
Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant Form.
Int J Mol Sci
; 17(9)2016 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-27563879
9.
Prevalence of SARS-CoV-2 antibodies and associated factors in the adult population of Belgium: a general population cohort study between March 2021 and April 2022.
Arch Public Health
; 82(1): 72, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38750563
10.
Hybrid Immunity Overcomes Defective Immune Response to COVID-19 Vaccination in Kidney Transplant Recipients.
Kidney Int Rep
; 9(3): 635-648, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38481503
11.
A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo.
Hepatology
; 55(2): 364-72, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21953761
12.
Validation of a rapid SARS-CoV-2 antibody test in general practice.
BMJ Open
; 13(5): e069997, 2023 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37130685
13.
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
Vaccine
; 41(17): 2829-2836, 2023 04 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36997386
14.
In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus.
Hepatology
; 53(3): 755-62, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21319203
15.
Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparum.
Malar J
; 11: 384, 2012 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-23173602
16.
Development and validation of a microfluidic multiplex immunoassay for the determination of levels and avidity of serum antibodies to tetanus, diphtheria and pertussis antigens.
J Immunol Methods
; 503: 113245, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35248526
17.
Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients.
Front Immunol
; 13: 827242, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35309332
18.
Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study.
Viruses
; 14(5)2022 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35632663
19.
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up.
BMJ Open
; 12(9): e065897, 2022 09 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36123069
20.
Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol.
BMJ Open
; 12(1): e054688, 2022 01 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35105642